Scarica l'app Stockscreener
1.81
3.72%
-0.07
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché BJDX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.88
Aprire:
$1.81
Volume 24 ore:
69,923
Relative Volume:
0.06
Capitalizzazione di mercato:
$2.70M
Reddito:
-
Utile/perdita netta:
$-8.59M
Rapporto P/E:
-0.00132
EPS:
-1373
Flusso di cassa netto:
$-9.25M
1 W Prestazione:
+1.12%
1M Prestazione:
+7.10%
6M Prestazione:
-48.58%
1 anno Prestazione:
-99.09%
Intervallo 1D:
$1.71
$1.9199
Intervallo di 1 settimana:
$1.71
$1.948
Portata 52W:
$1.46
$316.92
Bluejay Diagnostics Inc Stock (BJDX) Company Profile
Nome
Bluejay Diagnostics Inc
Settore
Industria
Telefono
(978) 631-0152
Indirizzo
360 MASSACHUSETTS AVENUE, SUITE 203, ACTON
Confronta BJDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BJDX
Bluejay Diagnostics Inc
|
1.81 | 2.67M | 0 | -8.59M | -9.25M | -1,373.00 |
|
ABT
Abbott Laboratories
|
131.30 | 234.53B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.50 | 156.88B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
376.62 | 150.65B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
80.68 | 110.81B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
74.99 | 45.75B | 5.54B | 4.18B | 623.10M | 7.00 |
Bluejay Diagnostics Inc Borsa (BJDX) Ultime notizie
Pre-market Movers: IXHL, KLRS, HCTI, DOCS... - RTTNews
Bluejay Diagnostics, Inc. SEC 10-Q Report - TradingView
Bluejay Diagnostics Inc (BJDX) Stock: A Comprehensive 52-Week Review - investchronicle.com
Bluejay Diagnostics Inc (BJDX)’s stock price range in the last year - uspostnews.com
BJDX stock touches 52-week low at $1.6 amid steep annual decline - Investing.com Canada
BJDX stock touches 52-week low at $1.6 amid steep annual decline By Investing.com - Investing.com South Africa
BJDX stock touches 52-week low at $2.22 amid sharp annual decline By Investing.com - Investing.com South Africa
BJDX stock touches 52-week low at $2.22 amid sharp annual decline - Investing.com India
Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting - The Manila Times
Breakthrough Sepsis Test Could Predict Patient Mortality Risk, New Study Reveals - Stock Titan
Small Cap Stocks To Watch NowApril 7th - MarketBeat
US Markets Rebound As Global Trade Tensions Persist - Finimize
United States shares lower at close of trade; Dow Jones Industrial Average down 0.84% - Investing.com India
Bluejay Diagnostics slumps after raising $3.7M through warrant exercise deal - MSN
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.84% - Investing.com
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.84% - Investing.com UK
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
BJDX stock touches 52-week low at $3.01 amid steep annual decline By Investing.com - Investing.com South Africa
BJDX stock touches 52-week low at $3.01 amid steep annual decline - Investing.com
Dow Jumps Over 1,100 Points; US Small Business Sentiment Falls In March - Benzinga
Wall Street Attempts Recovery From Tariff-Driven Losses as US Equity Futures Rise Pre-Bell - TradingView
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Jack Kellogg Called The Market Bottom - timothysykes.com
Bluejay Diagnostics Plunges Premarket After Investors Agree to Exercise Warrants at Reduced Price - marketscreener.com
Bluejay Diagnostics Sinks Premarket Following Investor Agreement to Exercise Warrants at 'Reduced' Price - marketscreener.com
Bluejay Diagnostics enters into agreement with institutional investors - Medical Buyer
Why Levi Strauss Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga
Bluejay Diagnostics Raises $3.7M Through Warrant Deal, Stock Slides After-Hours While Retail Interest Surges - NewsBreak: Local News & Alerts
Bluejay Diagnostics (BJDX) Secures $3.7M Through Warrant Exercis - GuruFocus
Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds - The Manila Times
Bluejay Diagnostics Announces Entry Into Warrant Inducement Transaction For Approximately $3.7 Million In Gross Proceeds - marketscreener.com
Bluejay Diagnostics Raises Fresh $3.7M Capital: New Warrant Deal Strengthens Balance Sheet - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Vermilion Energy Inc. Confirms First Quarter 2025 Release Date and Filing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders - Yahoo Finance
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
'Magnificent 7' stocks continue getting hammered as Trump tariffs drag markets lower - Yahoo Finance
Nasdaq Surges Over 400 Points; China Pharma Shares Plummet - Benzinga
VR ‘transforming medical field’ through training, prototyping, treatment - Yahoo
ADDING MULTIMEDIA Altus Capital Partners Together With Centerfield Capital and ALM Management Acquire ALM Positioners, Inc. - Yahoo Finance
Ardonagh Advisory acquires ALP Holdings and its subsidiary - Yahoo Finance
Diagnostic Green Announces the Return of IC-Green® to the Market and Corporate Support for Groundbreaking Cancer Trial - Yahoo Finance
Bluejay Diagnostics: A Roller Coaster Week - timothysykes.com
IBM Acquires Hakkoda Inc., Expanding Data Expertise to Fuel Clients' AI Transformations - Yahoo Finance
Berkshire Hathaway (BRK-B) And Vltava Fund’s Investment Approach - Yahoo Finance
Is United Rentals (URI) Trading at Attractive Price? - Yahoo Finance
Stramsen Biotech Inc. Announced $25 Million Funding Commitment from GEM Global Yield LLC SCS ("GEM") - Yahoo Finance
Is It Too Late To Consider Buying Performance Food Group Company (NYSE:PFGC)? - Yahoo Finance
Oil drops to four-year low, metals fall on recession fears - Yahoo Finance
Is Enlivex Therapeutics (NASDAQ:ENLV) In A Good Position To Invest In Growth? - Yahoo Finance
Cintas Corporation (CTAS) Dropped -11% in Q4 - Yahoo Finance
Hub Group, Inc.'s (NASDAQ:HUBG) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong? - Yahoo Finance
Bluejay Diagnostics Inc Azioni (BJDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.11%
0.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):